Singapore markets closed

AN2 Therapeutics, Inc. (ANTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4300+0.0600 (+2.53%)
As of 03:54PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.62-0.63-2.57-2.45
Low estimate-0.67-0.73-3.05-2.85
High estimate-0.56-0.54-2.19-1.83
Year ago EPS-0.79-0.81-2.74-2.57
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.68-0.85-0.63-0.75
Actual EPS-0.79-0.81-0.65-0.57
Difference-0.110.04-0.020.18
Surprise %-16.20%4.70%-3.20%24.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.62-0.63-2.57-2.45
7 days ago-0.62-0.63-2.57-2.45
30 days ago-0.76-0.75-2.89-2.94
60 days ago-0.76-0.75-2.89-2.97
90 days ago-0.76-0.75-3.04-3.43
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4432
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesANTXIndustrySector(s)S&P 500
Current qtr.21.50%N/AN/AN/A
Next qtr.22.20%N/AN/AN/A
Current year6.20%N/AN/AN/A
Next year4.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A